AnalytiCon Discovery To Identify New Natural Compounds For Johnson & Johnson Pharmaceutical Research & Development

13-Jul-2005

AnalytiCon Discovery GmbH (AnalytiCon), a specialist in all aspects of natural product drug discovery, announced it has signed an agreement that will provide Johnson & Johnson Pharmaceutical Research & Development, Division of Janssen Pharmaceutica N.V. (J&JPRD), with full access to the unique chemical diversity contained within AnalytiCon's extensive natural products biological collection. Financial terms of the agreement were not disclosed.

According to the agreement, AnalytiCon will apply its proprietary MEGAbolite® technology to isolate and characterize small molecule compounds from a variety of biosources to find novel and pharmaceutically active compounds on behalf of J&JPRD. AnalytiCon will profile both its own extensive proprietary biological collections and biomaterials provided by Tibotec Pharmaceuticals Ltd. (Tibotec) that are described in ethnobotany for active compounds. In addition, AnalytiCon will carry out all tasks beginning with the acquisition of plant and microbial material, and the isolation and fractionation of the contained natural product compounds up to their analytical characterization. AnalytiCon expects to deliver more than 500 highly purified compounds with fully elucidated structures to J&JPRD and Tibotec for drug discovery screening activities. AnalytiCon also expects to establish the resupply protocol in order to guarantee compound supply for J&JPRD's followup discovery work on an as-needed basis.

"We have had a long business relationship with J&JRPD and we are excited to continue this relationship," said Dr. Lutz Müller-Kuhrt, CEO of AnalytiCon Discovery GmbH. "We expect to supply a number of novel compounds and we look forward to working with J&JPRD within their discovery process."

The internationally operating AnalytiCon Discovery GmbH is a worldwide market-leader in the field of structurally fully elucidated natural product libraries. On the basis of its ready-to-screen technology in the field of natural products (MEGAbolite®) and natural product analogues (NatDiverseTM) the company enjoys an exceptional market positioning. AnalytiCon has direct access to roughly a quarter of all known natural compounds worldwide, i.e. in their pure and structurally fully elucidated form. The company is able to offer its clients a complete Supply-Chain-Management from the initial biomaterial to the final lead compound.

https://www.bionity.com/en/news/47645/analyticon-discovery-to-identify-new-natural-compounds-for-johnson-johnson-pharmaceutical-research-development.html